LY2922470

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY2922470, covering 2018-07-26 to 2019-06-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2922470 in Healthy Participants and Participants With Diabetes [Phase 1]